Search results - 4 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
(SARI) from December 2021 to July 2022 (Omicron-dominant period).MethodsIn both networks, 46 hospitals (13 countries) follow a similar test-negative case-control protocol. We defined complete primary ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
2021.MethodsForty-six participating hospitals across 14 countries follow a similar generic protocol using the test-negative case-control design. We defined complete primary series vaccination (PSV) as two doses of ...
A comparison of COVID-19 incidence rates across six European countries in 2021.
David; Pistol, Adriana; Javiera Rebolledo; Riccardo, Flavia; Riess, Maximilian; Rusu, Lavinia Cipriana; Che, Didier; Coignard, Bruno; COVID-19 Study group; COVID-19 Study Group members Source: Euro ...
Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023.
ADOLESCENT Adult Case-Control Studies Child denmark Humans Influenza A Virus, H1N1 Subtype Influenza A Virus, H3N2 Subtype Influenza B virus Influenza Vaccines Influenza, Human Male middle aged Seasons ...